Medications associated with Overactive Bladder
Ingredients whose current FDA labeling lists an association with overactive bladder, extracted from manufacturer submissions via NIH DailyMed.
Label-linked ingredients
Darifenacin
ENABLEX® (darifenacin) extended-release tablets are indicated for the treatment of overactive bladder with s...
Fesoterodine
Toviaz® is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge uri...
Oxybutynin
Oxybutynin chloride extended-release tablets are once daily controlled-release tablets indicated for the treat...
Solifenacin
Solifenacin succinate tablets is a muscarinic antagonist indicated for the treatment of overactive bladder wit...
Tolterodine
Tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urina...
Trospium
Trospium Chloride Extended-Release Capsules are a muscarinic antagonist indicated for the treatment of overact...
Lab tests that investigate overactive bladder
Frequently Asked Questions
What medications are used for overactive bladder?
The medications listed above are associated with overactive bladder in current FDA-approved labeling as reported by manufacturers through NIH DailyMed. Only a qualified prescriber can determine appropriate treatment.
Do these medications cure overactive bladder?
This site does not provide treatment advice. The list reflects labeled associations, not recommendations. Discuss options, risks, and benefits with your healthcare provider.
Medical disclaimer: Educational content only. Not medical advice or a treatment recommendation.